Irreversible imatinib-induced pneumonitis following long-term imatinib administration.
Seki
Nobuhiko
N
Division of Medical Oncology, Tokai University School of Medicine, Isehara. seki@is.icc.u-tokai.ac.jp
Ito
Akemi
A
Watanabe
Kennichi
K
Shibakuki
Reishi
R
Seto
Takashi
T
Uematsu
Kazutsugu
K
Mine
Tetsuya
T
Eguchi
Kenji
K
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D008297:Male; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D011859:Radiography
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate